Pepsinogen 4, Group I (Pepsinogen A) (PGA4) (C-Term) Peptid

Details zu Produkt Nr. ABIN981623, Anbieter: Anmelden zum Anzeigen
Proteinname
  • PGA3
  • PGA5
  • pepsinogen 4, group I (pepsinogen A)
  • PGA4
Protein Region
C-Term
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-PGA4 Antikörper (Pepsinogen 4, Group I (Pepsinogen A)) (C-Term) (ABIN2790303)
Sequenz IACAEGCQAI VDTGTSLLTG PTSPIANIQS DIGASENSDG DMVVSCSAIS
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PGA4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Proteinname
Hintergrund PGA4 shows particularly broad specificity, although bonds involving phenylalanine and leucine are preferred, many others are also cleaved to some extent.

Alias Symbols: FLJ58952, FLJ77962, PGA3, PGA5

Protein Size: 388
Molekulargewicht 42 kDa
Gen-ID 643847
NCBI Accession NM_001079808, NP_001073276
UniProt P0DJD7
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.